Skip to main content
. 2024 Nov 15;150(11):500. doi: 10.1007/s00432-024-05966-1

Table 2.2.

Distribution of maximum recorded value of inflammatory markers and coagulation factors across patients from different categories of cancer and no cancer

Laboratory Parameters No Cancer
N = 50,568
Unspecified Cancer
N = 541
Hematological
N = 147
Solid Cancer
N = 288
P
Value*
Inflammatory marker
Total leukocyte Count (Cells /mm3) 8890 (5980, 12,500) 8900 (5600, 13,500) 10,300(4000, 22,800) 9200 (6500, 14,700) 0.016
CRP (mg/L) 44.49(10.5, 124) 56.08 (8.8, 102) 61.4 (15.9, 147.4) 73 (14.3, 125.505) 0.1169
LDH (IU/L) 454 (291, 658) 426 (286.5, 696) 455.5 (352.3, 696) 370.6 (265, 580) 0.04
Ferritin (ng/ml) 452 (170.15, 698) 489 (188.15, 1000) 749.55(304.55, 1768.5) 378 (168.3, 1019) 0.15
Procalcitonin (ng/ml) 0.222 (0.1, 0.88) 0.224 (0.1, 0.86) 0.84 (0.41, 7.6) 1.04 (0.25, 4.22) 0.003
IL 6_level (pg/ml) 19.3 (6.2, 65.59) 34.45 (10.34, 99.08) 43.8 (11.2, 74) 70 (29.8, 284.2) 0.003
Coagulation
PT (seconds) 13.8 (12.3, 15.6) 14.6 (13.2, 16.7) 14.7 (12.4, 17.9) 13.4 (11.8, 16.35) 0.41
INR 1.09 (1, 1.21) 1.16 (1.02, 1.339) 1.16 (1.08, 1.41) 1.14 (1.02, 1.3)  < 0.001
D_Dimer (mg/L) 0.92 (0.36, 5.19) 0.83 (0.27, 2.25) 1.1 (0.46, 4.03) 1.2 (0.57, 3.11)  < 0.001

*P value for Kruskal wallis test